Table of Contents
PHILADELPHIA — Wolters Kluwer Health has completed its purchase of Lexi-Comp Inc., a global provider of drug information and clinical content for pharmacists, clinicians and hospitals.
The company said Friday that the deal, unveiled in late April, is the latest in a series of strategic acquisitions it has made in its clinical solutions business as part of a focus on the point-of-care market. Terms of the acquisition weren’t disclosed.
Based near Cleveland, Lexi-Comp provides services and content to about 1,500 hospitals internationally, has more than 1,700 drug monographs and is particularly strong in the area of mobile content for pharmacists and clinicians, according to Wolters Kluwer. To support and supplement clinician-patient interactions, Lexi-Comp also provides patient medication leaflets in 19 languages.
"This acquisition is very much aligned with our growth strategy of building out our strong portfolio of clinical decision support solutions to further our leadership position in the point-of-care market," commented Arvind Subramanian, president and chief executive officer of Wolters Kluwer Health Clinical Solutions. "This strategy will enable our customers to access leading clinical content, drug information for retail and hospital pharmacies, and innovative mobile offerings."
